Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Organogenesis Holdings Inc's Business Segments
Organogenesis Holdings Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
2
Largest Segment
Product
Total Revenue
$ 44
Regions Reported
-
Revenue Share by Reportable Segment - FY
- Product0%
- Grant4.4%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 79 | - |
| Grant | $ 2 | 4.4% |
Revenue by Product & Service Category - FY
- Product97.4%
- Grant2.6%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 36 | 97.4% |
| Grant | $ 1 | 2.6% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Annual Results
Revenue Share by Reportable Segment - FY
- Product0%
- Grant4.4%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 79 | - |
| Grant | $ 2 | 4.4% |
Description of Organogenesis Holdings Inc
Organogenesis Holdings Inc is a globally recognized healthcare company that operates in the regenerative medicine and biomaterials industries. The company was founded in 1985 and is headquartered in Canton, Massachusetts. Organogenesis is committed to providing innovative solutions for wound healing, tissue regeneration, and surgical products that enhance the standard of care for patients globally.
Organogenesis Holdings focuses on developing products that are biologically-based and offer regenerative properties to promote healing and restoration of damaged tissues. The products developed by the company are based on advanced scientific research that integrates biological and physical factors to create a unique bioengineering product. The three main areas of focus for Organogenesis are Advanced Wound Care, Surgical & Sports Medicine, and Orthobiologics.
Advanced Wound Care is the primary focus of the company, and it offers an extensive product line to aid in the process of wound healing. The products developed for Advanced Wound Care include Apligraf, a bioengineered living cell product that aids in the healing of diabetic foot ulcers, venous leg ulcers, and pressure sores, and Dermagraft, a bioengineered dermal substitute that offers the ability to restore tissue for the treatment of chronic wounds.
Organogenesis Holdings aims to provide innovative surgical and sports medicine solutions for tissue repair, restoration, and healing. The company's products in this category include NuShield, a xenogenic tissue matrix that provides a barrier to soft tissue, and Allosync, a product that aids in the re-building of damaged cartilage.
Orthobiologics is a focus area of Organogenesis, and the company offers products that provide support and restoration for bone tissue. The products in this category include Gintuit, a product that is used for tissue regeneration and restoration, and NuCel, which is used for bone grafting and repair.
Organogenesis also places a great deal of focus on research and development to ensure that it remains at the forefront of the regenerative medicine industry. The company's R&D team is responsible for exploring new technologies and techniques that can be used to develop new products that offer better results to patients.
In conclusion, Organogenesis Holdings Inc is a leading healthcare company that is committed to research, development, and innovation in the regenerative medicine and biomaterials industries to ensure that it provides optimal solutions for tissue restoration and healing for patients globally.
Organogenesis Holdings focuses on developing products that are biologically-based and offer regenerative properties to promote healing and restoration of damaged tissues. The products developed by the company are based on advanced scientific research that integrates biological and physical factors to create a unique bioengineering product. The three main areas of focus for Organogenesis are Advanced Wound Care, Surgical & Sports Medicine, and Orthobiologics.
Advanced Wound Care is the primary focus of the company, and it offers an extensive product line to aid in the process of wound healing. The products developed for Advanced Wound Care include Apligraf, a bioengineered living cell product that aids in the healing of diabetic foot ulcers, venous leg ulcers, and pressure sores, and Dermagraft, a bioengineered dermal substitute that offers the ability to restore tissue for the treatment of chronic wounds.
Organogenesis Holdings aims to provide innovative surgical and sports medicine solutions for tissue repair, restoration, and healing. The company's products in this category include NuShield, a xenogenic tissue matrix that provides a barrier to soft tissue, and Allosync, a product that aids in the re-building of damaged cartilage.
Orthobiologics is a focus area of Organogenesis, and the company offers products that provide support and restoration for bone tissue. The products in this category include Gintuit, a product that is used for tissue regeneration and restoration, and NuCel, which is used for bone grafting and repair.
Organogenesis also places a great deal of focus on research and development to ensure that it remains at the forefront of the regenerative medicine industry. The company's R&D team is responsible for exploring new technologies and techniques that can be used to develop new products that offer better results to patients.
In conclusion, Organogenesis Holdings Inc is a leading healthcare company that is committed to research, development, and innovation in the regenerative medicine and biomaterials industries to ensure that it provides optimal solutions for tissue restoration and healing for patients globally.
Organogenesis Holdings Inc. is a prominent player in the field of regenerative medicine, specializing in the development, manufacturing, and commercialization of innovative products and services that address a variety of medical needs. Their offerings fall into three primary segments: Wound Healing, Surgical and Sports Medicine, and Orthopedics. Below is a comprehensive exploration of each segment and their corresponding products and services.
1. Wound Healing Segment
The Wound Healing segment is dedicated to addressing the challenges of chronic and acute wounds through advanced wound care and skin substitute products. The company’s offerings are designed to promote healing in a variety of wound types, including diabetic foot ulcers, venous leg ulcers, pressure ulcers, surgical wounds, and burns. Key products within this segment include:
- Apligraf: A pioneering skin substitute composed of living human cells that mimic the structure and function of normal skin. Apligraf is intended for the treatment of chronic wounds and works by promoting tissue regeneration and repair while offering a protective layer over the wound.
- Dermagraft: Developed specifically for diabetic foot ulcers, Dermagraft is a skin substitute that consists of human fibroblasts cultured on a collagen scaffold. This product helps restore the wound bed environment and promotes the healing process through cellular activity and collagen production.
- PuraPly: A bioengineered collagen matrix designed to facilitate the healing of chronic and acute wounds, surgical wounds, and burns. PuraPly acts as a scaffold for cellular migration and tissue repair and is effective in preventing infection.
- NuShield: This product features a dehydrated human amnion membrane that can be applied to enhance healing in various wound types. NuShield provides a natural tissue matrix that aids in reducing inflammation and promoting healing.
Surgical and Sports Medicine Segment
Organogenesiss Surgical and Sports Medicine segment centers around products designed for surgical procedures and the rehabilitation of sports-related injuries. These products facilitate tissue healing and reconstruction by providing supportive environments for regeneration. Notable products in this segment include:
- PuraMatrix: A nanofiber matrix composed of purified peptides, PuraMatrix serves as a permissive scaffold for soft tissue repair and regeneration following surgical interventions or injuries. Its unique structure promotes cellular infiltration and tissue formation.
- Nushield Flex: This amniotic membrane-based product is tailored for soft tissue repair in trauma and sports medicine contexts. Nushield Flex aids in reducing inflammation while providing an optimal microenvironment for tissue healing.
- Allopatch HD: Designed for surgical applications such as hernia repair, Allopatch HD is an acellular dermal matrix that supports tissue regeneration and healing. Its properties facilitate effective abdominal wall reconstruction by providing a scaffold for ingrowth.
- ReNu: A tissue-derived therapy aimed at tendon and ligament repair or augmentation. ReNu incorporates extracellular matrix components and growth factors to create a conducive healing environment that promotes tissue regeneration.
Orthopedics Segment
The Orthopedics segment focuses on products that aid in the repair and regeneration of bone and cartilage, particularly within the context of orthopedic surgeries. The emphasis here is on enhancing surgical outcomes and improving recovery. Key products include:
- NuCel: This human tissue-derived therapy is indicated for various orthopedic applications such as spinal fusion and bone reconstruction. NuCel provides a natural scaffold for bone growth and healing, enhancing the body’s inherent repair processes.
- RevitOs: A synthetic bone graft that mimics the properties of natural bone, RevitOs is used in orthopedic surgeries to facilitate bone regeneration. Its design promotes effective integration with the surrounding bone tissue.
- Gintuit: Gintuit is a cutting-edge therapy aimed at periodontal regeneration. It leverages human cells to help regenerate gum tissue and bone that have been lost due to periodontal disease, ultimately aiding in the restoration of oral health.
Conclusion
In summary, Organogenesis Holdings Inc. is at the forefront of regenerative medicine, offering a comprehensive array of products and services designed to heal and regenerate tissues across different medical fields. By focusing on innovative solutions for wound healing, surgical and sports medicine, and orthopedics, the company plays a vital role in improving patient outcomes and advancing the standards of care in regenerative therapies.
1. Wound Healing Segment
The Wound Healing segment is dedicated to addressing the challenges of chronic and acute wounds through advanced wound care and skin substitute products. The company’s offerings are designed to promote healing in a variety of wound types, including diabetic foot ulcers, venous leg ulcers, pressure ulcers, surgical wounds, and burns. Key products within this segment include:
- Apligraf: A pioneering skin substitute composed of living human cells that mimic the structure and function of normal skin. Apligraf is intended for the treatment of chronic wounds and works by promoting tissue regeneration and repair while offering a protective layer over the wound.
- Dermagraft: Developed specifically for diabetic foot ulcers, Dermagraft is a skin substitute that consists of human fibroblasts cultured on a collagen scaffold. This product helps restore the wound bed environment and promotes the healing process through cellular activity and collagen production.
- PuraPly: A bioengineered collagen matrix designed to facilitate the healing of chronic and acute wounds, surgical wounds, and burns. PuraPly acts as a scaffold for cellular migration and tissue repair and is effective in preventing infection.
- NuShield: This product features a dehydrated human amnion membrane that can be applied to enhance healing in various wound types. NuShield provides a natural tissue matrix that aids in reducing inflammation and promoting healing.
Surgical and Sports Medicine Segment
Organogenesiss Surgical and Sports Medicine segment centers around products designed for surgical procedures and the rehabilitation of sports-related injuries. These products facilitate tissue healing and reconstruction by providing supportive environments for regeneration. Notable products in this segment include:
- PuraMatrix: A nanofiber matrix composed of purified peptides, PuraMatrix serves as a permissive scaffold for soft tissue repair and regeneration following surgical interventions or injuries. Its unique structure promotes cellular infiltration and tissue formation.
- Nushield Flex: This amniotic membrane-based product is tailored for soft tissue repair in trauma and sports medicine contexts. Nushield Flex aids in reducing inflammation while providing an optimal microenvironment for tissue healing.
- Allopatch HD: Designed for surgical applications such as hernia repair, Allopatch HD is an acellular dermal matrix that supports tissue regeneration and healing. Its properties facilitate effective abdominal wall reconstruction by providing a scaffold for ingrowth.
- ReNu: A tissue-derived therapy aimed at tendon and ligament repair or augmentation. ReNu incorporates extracellular matrix components and growth factors to create a conducive healing environment that promotes tissue regeneration.
Orthopedics Segment
The Orthopedics segment focuses on products that aid in the repair and regeneration of bone and cartilage, particularly within the context of orthopedic surgeries. The emphasis here is on enhancing surgical outcomes and improving recovery. Key products include:
- NuCel: This human tissue-derived therapy is indicated for various orthopedic applications such as spinal fusion and bone reconstruction. NuCel provides a natural scaffold for bone growth and healing, enhancing the body’s inherent repair processes.
- RevitOs: A synthetic bone graft that mimics the properties of natural bone, RevitOs is used in orthopedic surgeries to facilitate bone regeneration. Its design promotes effective integration with the surrounding bone tissue.
- Gintuit: Gintuit is a cutting-edge therapy aimed at periodontal regeneration. It leverages human cells to help regenerate gum tissue and bone that have been lost due to periodontal disease, ultimately aiding in the restoration of oral health.
Conclusion
In summary, Organogenesis Holdings Inc. is at the forefront of regenerative medicine, offering a comprehensive array of products and services designed to heal and regenerate tissues across different medical fields. By focusing on innovative solutions for wound healing, surgical and sports medicine, and orthopedics, the company plays a vital role in improving patient outcomes and advancing the standards of care in regenerative therapies.